Based on single cell data analysis, the expression of MT2A, MT1X and MT1E decreased in ESCC patients resistant to PD-1 monoclonal antibody, which may be related to PD-1 mMAB resistance. This evidence concerns the gene MT2A and esophageal squamous cell carcinoma.